Winn CIPP Welcomes Cohort 4 Medical Students Focused on Connecting Communities to Clinical Research
The Robert A. Winn Clinical Investigator Pathway Program (Winn CIPP), a national program out of VCU Massey Comprehensive Cancer Center, has officially launched its fourth annual cohort, taking place during the summer of 2025.
Markey Researchers Awarded $6.8 Million To Help Others Replicate Kentucky’s Lung Cancer Screening Success
A groundbreaking lung cancer screening project co-led by the University of Kentucky Markey Cancer Center and the University of Colorado (CU) Cancer Center is set to expand its reach, thanks to a $6.8 million grant from the Bristol Myers Squibb Foundation.
Improving Access to Care by Strengthening Local Health System Capacity
We are in an era of unprecedented medical innovation. Scientists are making remarkable progress to diagnose and treat diseases, bringing new hope to patients across the world. Unfortunately, these breakthroughs fail to reach everyone due to barriers to care.
Bristol Myers Squibb Named to Dow Jones Sustainability Index North America for Second Consecutive Year
Bristol Myers Squibb announced that it has been named in the prestigious Dow Jones Sustainability Index (DJSI) for the second consecutive year. This recognition further validates the company’s impactful progress towards and prioritization of its ESG initiatives and aspirations.
One Community at a Time: Enabling Early Lung Cancer Detection Across the U.S.
Early detection through screening is key to improving lung cancer survivorship – when lung cancer is discovered early enough to be surgically removed before spreading, a patient's chance of surviving five years jumps from 4% to 55%.
Bristol Myers Squibb Promotes Health Equity with 100 Percent of Marketed Products Now Supported by Access Plans
At BMS, our vision to transform patients’ lives through science extends to all patients. That is why we have a long-standing commitment to promote health equity and help people in underserved communities access the care and medicines they need.
Bristol Myers Squibb's Commitment to Environment, Social and Governance: Our Progress & Aspirational Goals
At BMS, we understand that the future of our company, employees, communities, and the planet are inextricably linked. Our passion for making an impact extends beyond the discovery, development and delivery of innovative medicines that help patients prevail over serious diseases.
Bristol Myers Squibb Reaches Major Milestone in Environmental Sustainability
BMS today announced validation for its near-term and net-zero science-based targets from the Science Based Targets initiative (SBTi), as part of a mid-year update on its environmental initiatives, highlighting progress in reducing emissions across its operations and supply chain.
BMS Named 2024 Best Place to Work for Disability Inclusion in US, UK and Brazil by the Disability Equality Index®
BMS has earned a top score of 100 on the 2024 Disability Equality Index®, naming BMS a Best Place to Work for Disability Inclusion in the U.S., U.K. and Brazil. BMS has earned this score for the sixth consecutive year in the U.S. and for the first time in the U.K. and Brazil.
ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries
Globally, communities are struggling to support growing healthcare needs. This is especially true in regions with limited financial resources, collectively known as low- and middle-income countries (LMICs). Although LMIC populations have grown nearly four times faster.